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Abstract
A general objective of genetic studies is to understand the genetic basis of complex traits such as
height, body mass index (BMI), disease endpoints, etc. Such researches have been facilitated due to
the completion of the human genome project and developments of high-throughput technologies.
With the help of high-throughput genotyping and sequencing technologies, the information on
millions of genetic markers can be measured for each individual.
The most widely used strategy to detect the associations between genetic variants and a com-
plex trait is genome-wide association study (GWAS). Because the genetic architecture of most
complex traits is highly polygenic, the signal to noise ratio is usually tiny. Thus, especially in
human populations, GWAS often requires large samples to obtain sufficient power. Unfortunately,
given the restrictions on sharing individual-level data, it is often not feasible to pool data from
different cohorts. Despite that, in each cohort, it is possible to report and share GWAS sum-
mary statistics, such as sample sizes, allele frequencies, estimates of genetic effect sizes, and their
standard errors for the genetic markers across the genome. Therefore one recent focus in sta-
tistical methodology development for genetic studies has been on meta-analysis techniques using
summary-level data. The objective of this thesis is to develop novel statistical genetics methods
based on GWAS summary statistics and to apply these methods to better understand the genetic
architecture underlying complex traits.
In Study I, we developed a Selection Operator for JOint analyzing multiple SNPs (SOJO).
We mathematically proved and empirically showed that the least absolute shrinkage and selection
operator (LASSO) could be achieved using GWAS summary-level data. Compared to the stepwise
selection procedures, SOJO performs better in variable selection. SOJO is useful for detecting
additional variants with independent effects and assessing the magnitude of allelic heterogeneity
within loci.
In Study II, we developed a High-Definition Likelihood (HDL) method to improve the accu-
racy in genetic correlation estimation using GWAS summary statistics. Compared to the state-
of-the-art method LD Score regression (LDSC), HDL achieves higher statistical power to detect
genetic correlations between phenotypes by fully accounting for linkage disequilibrium (LD) infor-
mation across the genome.
In Study III, we introduced a four-level strategy for replication of loci detected by multi-trait
GWAS methods. The four methods provide different degrees of replication strength, useful for
providing additional evidence when a locus has been discovered and replicated by multivariate
analysis of variance (MANOVA) or other multi-trait methods. The replication methods only
require summary association statistics and are straightforward to be applied to multi-trait GWAS
analyses.
In Study IV, using GWAS summary statistics, we developed a method named Genetic Corre-
lation Contrast for Causality (G3C) as a more robust test for the existence and direction of causal
relationships between phenotypes. In contrast to Mendelian Randomization (MR), G3C does not
rely on the assumption of no horizontal pleiotropy. G3C takes full advantage of genome-wide
genetic association data and account for underlying genetic correlations between complex traits.
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Chapter 1
GWAS and GWAS meta-analysis
GWAS
In terms of mapping genes and genetic variants affecting Mendelian traits, linkage analysis
has been successful (1). However, because of the relatively low power and resolution for
gene mapping, linkage analysis has had limited achievements when it comes to complex
traits or common diseases (2). In 1996, Risch and Merikangas (3) discussed the potential
power boosting by using association analysis instead of linkage analysis. This imaginative
design soon became reality because of the technological advances and biobanks established
around the world. The first discovery based on GWAS was reported in 2005 (4), where a
single-nucleotide polymorphism (SNP) was found to be associated with age-related mac-
ular degeneration. The study only included 96 cases and 50 controls, and 116,204 SNPs.
As of 2017, about 10,000 strong associations (P < 5×10−8) between genetics variants and
complex traits have been reported (5). According to the NHGRI-EBI GWAS Catalog (6),
as of 14 July 2020, 4,628 publications and 189,811 associations have been recorded. The
abundant results generated in GWASs facilitate geneticists’ understanding of the genetic
architecture underlying common diseases and complex traits.
According to GWAS results (7; 8; 9), most studied complex traits are highly polygenic,
which means many polymorphisms in many genes contribute to the genetic components of
the complex traits together. As a consequence, each single genetic variant can usually only
explain a small fraction of phenotypic variance. On the other hand, this also suggests that
larger sample size will lead to more discoveries, which has been happening during the past
years. Take human height as an example, in 2008, 54 SNPs had been identified and jointly
explained only ~5% heritability. By then, the sample size was ~63,000 (10). When the
sample size was enlarged to ~250,000 in 2014, the number of identified associated SNPs
increased to ~700, explaining ~20% of the trait’s heritability (7). As more and more new
GWAS data are still being collected, we can foresee more identified SNPs for each complex
trait in the next few years.
The numerous GWAS results suggest another implication: Widespread pleiotropy for
complex diseases and traits. For example, some GWAS indicated that the same SNP or
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gene set could be significantly associated with different traits, given that the phenotypes
are measured in independent samples (11). More evidence in auto-immune disease studies
implies that at some loci, the same causal variants can drive the observed association
across different diseases (12; 13).
GWAS has led to many scientific discoveries. However, many people have voiced their
concerns about GWAS. A major concern is the biological implication of the GWAS discov-
eries (14). By its design, an association reported by GWAS does not directly yield a causal
variant or a specific gene target of the underlying molecular mechanism (See chapter 3).
Nevertheless, GWAS discoveries play an important role as the first step of the discovery
pipeline. Based on GWAS signals, scientists have found several target genes by performing
subsequent functional experiments. For example, the FTO region harbours the strongest
genetic association with BMI (8). Following this signal, researchers discovered the under-
lying pathway between FTO region and IRX3 ; and IRX3 was suggested as a body mass
and composition regulator (15).
GWAS meta-analysis
GWAS meta-analysis can be used to combine results from multiple GWAS in indepen-
dent cohorts. By increasing sample size, GWAS meta-analysis boosts statistical power to
discover new genetic loci for common diseases and traits (16). Given the limited power
in single-cohort GWAS and the difficulty of sharing individual-level data, GWAS meta-
analysis based on summary-level data has become a popular approach, especially in human
genetics. In the past few years, most discovered associations were from large-scale GWAS
meta-analyses (17).
The most popular meta-analysis approach for synthesizing GWAS data is the fixed
effects model with inverse variance weights (17). Assuming the true effect of each causal
variant is the same across studies, the pooled estimator of effect size is
βˆM =
∑
j wj βˆj∑
j wj
,
with estimated variance of
Var(βˆM ) =
1∑
j wj
,
where the weight
wj =
1
Var(βˆj)
.
In some cases, the between-study heterogeneity is non-negligible (18). To take this het-
erogeneity into account, random effects model based on DerSimonian and Laird estimator
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can be used (19). The weight is calculated as
wRj =
1
1
wj
+ τˆ2
,where τˆ2 = Q− (k − 1)∑
j wj − (
∑
j w
2
j∑
j wj
)
. (1.1)
The Q in (1.1) is Cochran’s Q statistic for measuring the amount of between-study het-
erogeneity, which is given by
Q =
∑
j
wj(βˆj − βˆM )2.
Comparing to the random effects model, the fixed effects model had better discovery
power. Therefore the fixed effects model is more appropriate when the aim is to make
discoveries (20). On the other hand, the random effects model is preferable when the
generalizability of results is of interest, e.g., in prediction problems (18).
Chapter 2
Aims of the thesis
Summary statistics from GWAS or GWAS meta-analysis are valuable resources. Particu-
larly, they are sufficient statistics for many statistical genetics methods. With sufficient
information, methods based on summary-level data can perform similar to those based
on individual-level data. In many cases, summary-level methods are preferable because
(i) they allow a much larger sample size, which boosts statistical power; and (ii) they
are more computationally efficient. The overall aim of this thesis is to better analyze the
genetic architecture underlying complex traits by developing and implementing statistical
methods based on GWAS summary statistics. The specific aims of individual studies are:
I. To develop and implement the least absolute shrinkage and selection operator (LASSO)
using GWAS summary-level data for better fine-mapping.
II. To improve genetic correlation estimation using GWAS summary statistics based on
a full likelihood method.
III. To introduce a more rigorous and meaningful replication strategy for loci detected
by multi-trait GWAS methods, based on GWAS summary statistics.
IV. To provide a test for the existence and direction of causal relationships between
phenotypes, accounting for genetic correlations based on GWAS summary statistics.
Chapter 3
Fine-mapping and allelic heterogeneity
Fine-mapping
The number of SNPs considered in GWAS is small relative to the total number of ex-
isting SNPs in the genome. As a result, the causal variants, i.e., the genetic variants
causing the trait’s variation, are usually not included in GWAS. Despite that, GWAS has
successfully identified SNPs associated with complex traits across the whole genome. Why
does GWAS work even though the causal variants may not be included? The answer is
the correlation or linkage disequilibrium (LD) between the SNPs in GWAS and the actual
causal variants. If a SNP is correlated with a causal variant, the SNP will show some
signal in GWAS. In this case, the SNP is called a tag SNP or tagging SNP because it
tags the true causal variant (21). In other words, most SNPs suggested by GWAS are
tag SNPs instead of causal variants themselves (22). At this point, we need fine-mapping
methods to refine the genomic localization of causal variants.
A typical flow of the fine-mapping process is shown in Fig 3.1. Because the regional LD
structure can be complicated, fine-mapping becomes challenging, especially when a locus
harbors multiple causal variants. Early efforts were put on so-called LD clumping, which
filters out the SNPs correlated to the lead SNP. As a simple fix, LD clumping does not
account for the joint effects of the SNPs. Therefore SNPs can be filtered out barely due to
their mild LD with the lead SNP, even though they may tag independent causal variants.
To solve this issue, GCTA-COJO (23) and Bayesian methods (24) were developed to model
multiple tag SNPs jointly. A short introduction to these methods will be provided in the
later sections in this chapter.
After identifying potential SNPs tagging independent causal variants, how can we be
confident that they are real discoveries? There is a common hypothesis that a causal
variant affects traits by regulating the expression of a nearby gene in some tissues. There-
fore, besides replicating the SNPs in another cohort, we can investigate whether they are
expression quantitative trait loci (eQTL) (25). If a SNP is significant in both GWAS and
eQTL analysis, then the colocalization information makes the pathway and the discovered
SNP more convincing (26). However, in many cases, GWAS loci are not necessarily strong
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eQTL (25). Instead, they may regulate genes in other ways, such as alternative splicing
(27).
Figure 3.1: A typical flow of fine-mapping process from GWAS to annotation of SNPs selected
from fine-mapping. The figure is reprinted from Schaid et al. (28) with permission from Springer
Nature.
Allelic heterogeneity
Allelic heterogeneity (AH) is the phenomenon when there are multiple causal variants
at the same locus for a trait. Different from polygenicity, which measures the spread of
genetic effects across the genome, AH evaluates the spread of genetic effects within each
locus. Hence AH together with polygenicity measure the complexity of a trait. AH of
some Mendelian traits such as cystic fibrosis has been well studied (29). As a contrast,
the extent of AH for complex traits is unclear. Although AH is reported to be present in
various complex diseases (30), more evidence and quantitative results are needed.
GCTA-COJO
GCTA-COJO represents conditional and joint multiple-SNP analysis. Based on GWAS
meta-analysis summary statistics, GCTA-COJO performs a secondary association scan
conditioning on the discovered top variants. For an individual, assuming a quantitative
trait y is potentially affected by a group of genetic variants X1, ..., Xp and a multi-variant
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linear model
y = Xβ + e.
The joint effects of multiple SNPs estimated by the least-squares are
βˆ = (XTX)−1XTy, and Var(βˆ) = σ2J(XTX)−1,
where XTX can be estimated from the LD structure of a reference sample, such as a
subcohort of the GWAS meta-analysis; and XTy can be estimated from GWAS meta-
analysis summary-level data. Then the joint p-values can be approximated. Conditional
p-values are derived similarly. Based on conditional p-values, a genome-wide stepwise
selection is performed. When there is no more variant can be added or removed in the
model, the joint effects and p-values are reported. GCTA-COJO has been widely applied in
global consortia such as GIANT and DIAGRAM (7; 8; 9; 31), where additional associations
in LD at the same loci were successfully detected.
The stepwise selection, which is implemented in GCTA-COJO, has been used as a stan-
dard variable selection procedure in many fields. After measuring variables, researchers
frequently perform multiple linear regression analyses to select relevant variable subsets
and derive models. The most straightforward technique is to check all possible variable
subsets and select the best one. However, considering the number of different combinations
of variables, the amount of computation can be intractable even when efficient algorithms
are implemented (32). Therefore stepwise methods such as forward selection and backward
elimination are used. But in the forward selection, a formerly selected variable may be-
come unimportant as other variables enter the model; similarly, in backward elimination,
a former deleted variable may become important as other variables are removed from the
model. To deal with these problems, the stepwise selection procedure was developed (33).
The stepwise selection is a combination of the forward and backward selection: Variables
are added to the model one at a time; and at each step, backward elimination is performed
to see whether variables can be removed from the model.
However, the literature suggests that the stepwise selection is very likely to remove
some useful variables which are in mild correlation with selected predictors (34). This
indicates that GCTA-COJO may miss some informative tag SNPs due to their mild LD
with selected variants. By setting a less stringent significance threshold, more variants can
be selected. But there will be a substantial risk of overfitting for the model generated by
the stepwise selection, especially when the model includes many variants (35).
LASSO
Comparing to the stepwise selection, literature suggests that simultaneous modeling of
multiple predictors with penalization performs better in variable selection (36). In 1996,
Tibshirani introduced the least absolute shrinkage and selection operator (LASSO) (37),
which has been applied across various disciplines since then (38; 39). Besides the square
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loss function 12‖y−Xβˆ‖22, LASSO takes the ℓ1-norm regularization ‖βˆ‖1 into account and
solves
min
βˆ∈Rp
1
2
‖y−Xβˆ‖22 + λ‖βˆ‖1,
where the tuning parameter λ ≥ 0. The ℓ1 term serves as a penalization: the larger λ is,
the larger the coefficients are penalized. Because of the penalization term, large coefficients
are allowed only when they lead to substantially better fit. Consequently, LASSO can
perform variable selection, and achieves better interpretability and prediction accuracy
(37). Besides, by performing a more reasonable bias-variance trade-off with shrinkage,
overfitting problem is alleviated in LASSO. Therefore LASSO allows more informative
predictors in the model without serious overfitting. Owing to the LARS algorithm (34)
and regularization path algorithm (40), solving LASSO becomes computationally fast. In
recent decades, LASSO has been used in genetics researches to select variants (41) and
build prediction model (42).
In Study I, we developed a selection operator for jointly analyzing multiple variants
(SOJO). SOJO performed LASSO regression within each mapped locus by using summary
association statistics (43). SOJO has been shown to be more powerful than GCTA-COJO
in terms of both discovery and prediction.
Bayesian methods
Many Bayesian methods have been proposed for fine-mapping (44; 24; 45). The typi-
cal steps of the Bayesian methods are (i) assuming a prior distribution of the true effect
sizes; (ii) letting each SNP has two possible states: included or not included; (iii) com-
puting the posterior probabilities for the different models; (iv) computing the posterior
inclusion probability of each SNP and (v) selecting SNPs based on their posterior inclu-
sion probabilities. When the true causal variants are included in GWAS, comparing to
conditional analysis such as GCTA-COJO, Bayesian methods are shown to have a higher
probability of selecting the actual causal variants (24). However, it is worthy to note that
in most cases, the actual causal variants are not included in GWAS. Another disadvantage
of Bayesian methods is its heavy computational burden (24; 45).
Chapter 4
Genetic correlation
One genetic variant or locus can be causal for more than one trait. This phenomenon is
termed as pleiotropy. A real pleiotropy between two traits can be due to various biological
reasons (46), such as causation or sharing a common biological process. One step further,
genetic correlation evaluates the alignment of pleiotropy across the whole genome. An
extensive existence of genetic correlations between complex traits and diseases has been
reported (47; 13). Genetic correlation can help understand the shared biology underlying
complex traits. Following significant genetic correlations between traits, different methods
can be used to (i) perform causal inference (48), (ii) improve power to detect new associ-
ations by modelling multiple traits simultaneously (See chapter 5), (iii) improve genetic
risk prediction (49) and (iv) better understand the relationships between traits by further
modelling genetic correlated traits (50).
The mathematical definition of genetic correlation is based on the general quantitative
genetic model. For each individual, the phenotype of trait 1 (y1) is the sum of a genetic
value (g1) and a residual (e1):
y1 = g1 + e1.
Similarly for the phenotype of trait 2 (y2):
y2 = g2 + e2.
Denoting the genetic variance of the two traits as σ2g1 and σ
2
g2 respectively, and the covari-
ance of the genetic values as σg1,g2 , the genetic correlation (rg) is defined as
rg =
σg1,g2√
σ2g1σ
2
g2
.
If the phenotypic variances of the two traits are standardised to one, and the genetic
values are limited to only additive effects, then the genetic variances σ2g1 and σ
2
g2 become
narrow-sense heritabilities h21 and h22, and the genetic covariance σg1,g2 is represented by
coheritability h12.
Conventionally, to estimate h21, h22 and h12, a bivariate linear mixed model (LMM) is
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applied to a cohort with pedigree information. Then the parameters can be estimated
using restricted maximum likelihood (REML) (51). However, given the difficulty of col-
lecting complete family data, the power of family-based methods is often limited by the
small sample size. Large sample size can be obtained from national registries (52), which
is available only in a few countries. Besides, the shared environmental factors within fam-
ilies may bias the estimates.
Bivariate GREML
Thanks to the advance of genomic technology, more and more large cohorts with geno-
types and phenotypes of independent individuals have become available. To estimate h21,
h22 and h12 based on data from independent individuals, Yang et al. developed genome-
based REML (GREML) in their genome-wide complex trait analysis (GCTA) software
(53). Similar to REML for pedigree data, GREML also uses an LMM. In REML for
pedigree data, the variance-covariance structure is derived from a kinship matrix; while
in GREML, the kinship matrix is replaced by a genomic relationship matrix (GRM) de-
rived from genome-wide SNP genotype data. Conceptually, all “independent individuals”
are distant relatives. The GRM is a good approximation of the kinship between distant
relatives. Bivariate GREML (54) can estimate h21, h22, h12 and rg simultaneously.
GREML has been widely used since its inception (55; 56; 57). However, REML itself
is computationally intensive. Although various algorithms have been suggested to speed it
up (58; 59; 60), REML is still computationally challenging when the number of individuals
is very large such as in UK Biobank (UKB).
LD Score regression
In GWAS, the χ2 association statistic for a SNP is driven by the effects of all SNPs
tagged by this SNP (61). Therefore, for polygenic traits, SNPs having higher LD with
other SNPs tend to have higher χ2 statistics on average. Motivated by this fact, LD Score
regression (LDSC) was developed (62). Because LDSC only relies on GWAS summary
statistics, it is computationally very efficient and convenient to use.
In LDSC, under the same LMM as in GCTA, the expected χ2 statistic for variant j is:
E
[
χ2j | lj
]
=
Nh2
M
lj +Na+ 1, (4.1)
where lj =
∑
k r
2
jk is called as the LD Score of variant j, which measures the amount of
genetic variation captured by variant j; N is the sample size; M is the number of variants
in the polygenic model and a is the contribution of confounding biases such as population
stratification. When there are two traits, and the confounding biases are absent, equation
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(4.1) can be extended to
E [z1jz2j | lj ] =
√
N1N2h12
M
lj +
ρNs√
N1N2
, (4.2)
where h12 is the genetic covariance; Ni is the sample size for study i; Ns is the number
of overlapping individuals; and ρ is the phenotypic correlation among the Ns overlapping
samples. Then genetic correlation can be computed as rg = h12/
√
h21h
2
2, where h2i is the
heritability of trait i estimated from study i. This bivariate LDSC (47) has been widely
used in genetics and epidemiology to estimate genetic correlations between various traits
and diseases (63; 64). A centralized database and web interface has been developed to
integrate and get LDSC results for hundreds of traits/diseases (65).
As a ratio of genetic covariance and heritabilities, rg is a robust estimate because the
biases on the numerator and the denominator often cancel out (66). rg from LDSC has
been shown to be robust against multiple factors, such as model misspecification (67),
scale transformation (47), ascertainment of cases and strong environmental factors (68).
However, it is worthy to note that the efficiency of LDSC is lower than that of GREML
(47), even when the GWAS sample and the reference sample matched.
In Study II, we introduced that LDSC only partially uses LD information, which is
an essential source generating the efficiency gap between LDSC and GREML. We proved
that the LD matrix determined not only the variance of the single SNP test statistic but
also the whole variance-covariance matrix of the test statistics. Therefore (4.1) and (4.2)
can be extended to
Cov [zi] =
Nih
2
i
M
L+R
Cov [z1, z2] =
√
N1N2h12
M
L+ Ns(h12 + ρ)√
N1N2
R
where zi is the Z score vector of the M SNPs from study i of trait i, R is the LD matrix
of the M SNPs, L := R′R is the LD score matrix.
To fully use LD information, we developed high-definition likelihood (HDL) to es-
timate genetic correlations as a full likelihood-based method using summary-level data
(69). Comparing to LDSC, HDL estimates genetic correlations more accurately.
Chapter 5
Multi-trait methods
The small genetic effects of SNPs on complex traits limit the discovery power in most
GWAS. One approach to improve statistical power is jointly modeling multiple correlated
phenotypes (70). At the early stage, most multi-trait tools were based on individual-
level data. For example, the ––multivariate module of PLINK implements canonical
correlation analysis to identify the association between each SNP and linear combinations
of phenotypes (71); Combined-PC (72) performed a principal components analysis on the
phenotype data to improve statistical power.
In recent years, multi-trait methods based on GWAS summary-level data became popu-
lar. Many such methods have been developed and shown their benefits in terms of boosting
discovery power (73; 74; 75; 76). For example, Stephens (77) outlined a unified multivari-
ate analysis framework based on Bayesian model comparisons; Zhu et al. (78) introduced
two test statistics SHom and SHet to improve statistical power under different assumptions
of effect sizes, using which seven additional loci were suggested by jointly analyzing the
summary statistics of three traits from the GIANT consortium (79); MTAG (Multi-trait
analysis of GWAS) was developed to integrate GWAS summary results of multiple related
traits and improve the inference in each single-trait GWAS (49).
A simulation study (80) demonstrated that the statistical powers of most methods are
similar to the power of the standard multivariate analysis of variance (MANOVA). It has
been shown that MANOVA can be performed using summary statistics (77; 78). If we
denote the true marginal effects of a SNP on k traits by β, then the null hypothesis in
MANOVA is H0 : β = 0. Let t = [t1, ..., tk]′ be the vector of single-trait t-test statistics
from association tests between the genotypes g of a single SNP and the k phenotypes, and
R∗ ≡ cor(t | β) = Var(t | β). If R∗ is available, the test statistic
T 2 = t′R∗−1t,
which asymptotically follows a χ2 distribution with k degrees of freedom under the null
hypothesis. In practice, an unbiased estimate of R∗ can be obtained by selecting a large
number of independent variants from the GWAS summary statistics and calculating their
correlation coefficients (77; 78).
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Although most multi-trait methods can boost discovery power, the replication strategy
has yet to be agreed upon. When a SNP is discovered in multi-trait analysis, a commonly
used approach for replication is to replicate the associations trait-by-trait in a replication
sample (81; 82). However, there are two disadvantages of such “univariate” replication:
(i) when the number of tested traits is large, multiple testing arises when determining the
replication significance threshold; (ii) univariate replication does not normally account for
phenotypic correlations between the tested traits, which generates conservative significance
threshold after correction for multiple testing. Another straightforward way for replication
is to directly perform the multi-trait test in a replication sample and see whether the
overall association (omnibus p-value) is significant (83; 81; 84). Although this strategy
provides a unified test statistic, the consistency of the multiple genetic effects between the
discovery and replication samples is usually overlooked. Even if the genetic effect sizes
and directions are distinct between the discovery and replication samples, the multivariate
replication test may still declare significance.
In Study III, we introduced a four-level replication strategy for replication of loci de-
tected by multi-trait methods. The four methods provide different degrees of replication
strength, useful for extra evidence when a locus has been replicated by MANOVA or other
multi-trait methods. The replication methods only require summary association statistics,
straightforward to be applied to multi-trait GWAS analyses.
Pleiotropy and cross-phenotype association
Pleiotropy is normally defined as the same locus affecting multiple phenotypes (73); while
cross-phenotype (CP) association occurs when a locus or genetic variant is statistically
associated with multiple phenotypes, regardless of the causes of the observed associations
(Fig 5.1). Therefore CP association is necessary but not sufficient for pleiotropy with any
causal implication.
Nevertheless, practically, it is more promising to discover pleiotropy from loci with reli-
able and validated CP associations. Therefore, in Study III, we proposed the correlation
methods to replicate CP associations in a different cohort. This out-of-sample replication
can help rule out spurious pleiotropy. Spurious pleiotropy often arises in high linkage
disequilibrium (LD) region, where a SNP is more likely to tag multiple causal variants
located in different genes with distinct functions, such as in the major histocompatibility
complex region (85) and the immunoglobulin heavy chain (IGH ) locus (12). Given the
LD difference between discovery and replication samples, spurious pleiotropy is expected
to be rare among properly validated CP associations.
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Figure 5.1: Different types of pleiotropy. The figure is reprinted from Solovieff et al. (73) with
permission from Springer Nature.
Chapter 6
Causal inference using genetic data
A key objective of epidemiology and biomedical science is to understand the underlying
causalities between phenotypes. A real causality can serve as the foundation for public
policies or the target of drugs. However, it is challenging to infer causality from obser-
vational data. A primary issue is confounding, which introduces an association between
exposure and outcome in the absence of a causal relationship. For example, when we
study whether vitamin E is a protective factor for coronary artery disease (CAD), diet is
a confounder because it affects both vitamin E intake and CAD risk (86).
To tackle the confounding problem properly, a precise definition of causality is needed.
The most commonly used way to define causality is the counterfactual approach (87): An
individual is exposed in one world, while unexposed in another identical world. The only
difference between the two worlds is the exposure status of the individual. In this hypo-
thetical setting, a causal effect can be defined as the outcome difference of the individual
between the two worlds. Although such a scenario is impossible in reality, a consistent
estimate of causal effect can be attained if the exposure status in the real world is inde-
pendent to the potential counterfactual outcomes, which is termed as exchangeability. In
other words, exchangeability means that there is no systematical difference between the
exposed and non-exposed groups. Randomized controlled trial (RCT) ensures exchange-
ability by randomly split individuals into the exposed or non-exposed groups. Therefore
RCT is often regarded as the gold standard for causal inference.
Although RCT is powerful, it is usually expensive and sometimes infeasible or unethi-
cal to conduct. Thus causal inference based on observational data is often necessary and in
great need. Theoretically, if all confounders are controlled for, then conditional exchange-
ability can be reached, where exchangeability holds in each stratum of the combination
of confounders. In this case, the causal effect can be consistently estimated. However,
in reality, we can never rule out the existence of unobserved confounders and incorrectly
controlled confounders. Different confounder controlling is an important source that gen-
erates inconsistent results across observational studies.
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Mendelian Randomization
The emerging genetic data and genetically informed methods provide many useful tools
for causal inference (88). The most widely adopted one is Mendelian randomization (MR)
(89), where genetic variants are used as instrumental variables (IVs). To be a validate IV,
a genetic variant (usually a SNP) must satisfy three assumptions (Fig 6.1): Relevance,
exchangeability and exclusion restriction (88). In some literature, the exchangeability and
exclusion restriction assumptions are combined and referred as ‘no direct effect’ or ‘no
horizontal pleiotropy’ assumption, where direct effect and horizontal pleiotropy means the
variant affects the outcome through another pathway other than mediated by the expo-
sure. Under the above three assumptions, the effect of the variant on the outcome βGY
results only from the indirect effect mediated by exposure, which equals to βGX × βXY ,
where βGX is the effect of the variant on exposure, and βXY is the effect of the exposure
on the outcome. Then we can infer βXY by estimating βGY /βGX .
Figure 6.1: Directed acyclic graph and three assumptions in MR. Relevance (A1), the variant (G)
associates with the exposure (X); Exchangeability (A2), the variant is independent to all observed
(O) and unobserved confounders (U); Exclusion restriction (A3), conditional on exposure and
confounders, the variant is independent to the outcome (Y).
Although MR is straightforward to be understood and used, all of the three assump-
tions can be questionable. The relevance assumption is likely to be violated because the
association between a single SNP and the exposure is usually weak; the exchangeability
and exclusion restriction can be easily violated due to widespread pleiotropy (90). In
practice, the assumptions are mostly untestable, which undermines the reliability of MR
results.
To relax these assumptions and to make MR more robust, various methods have been
developed based on MR. Most methods only require GWAS summary statistics as in-
put source data. MR with multiple instruments is an essential extension. By analyzing
multiple instruments simultaneously, statistical power is increased (91; 92), and more im-
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portantly, the ‘no horizontal pleiotropy’ assumption can be relaxed and tested to some
extent. For example, inverse-variance weighted method (93) accepts invalid IVs as long as
their direct effects (i) are independent to their effects on the exposure and (ii) have a zero
mean; MR-Egger regression (94) further allows the direct effects to have non-zero mean;
Median-based methods allow some invalid IVs as long as at least 50% of the IVs are valid
(95); Mode-based methods give a consistent estimate when the invalid IVs have heteroge-
neous effect estimates (96); MR-PRESSO (90) can be used to detect horizontal pleiotropy.
The other efforts include two-sample MR (97) where the GWAS summary statistics for
exposure and outcome are from separate samples; Multivariable MR (98) includes several
variables as exposures to directly model possible pleiotropic pathways, and bidirectional
MR (99) aims to infer the direction of causation.
For each new MR-related method, although it relaxes MR assumptions to some extent,
it often introduces new untestable assumptions. Therefore in MR and causal inference lit-
erature, the importance of triangulation has been frequently emphasized (100; 101; 88).
Triangulation refers to the use of multiple approaches, preferably with distinct assump-
tions, to address the same question. If multiple methods agree on the same conclusion,
then the evidence is very strong, especially when the methods are distinct. In Study
IV, we introduced a method, fundamentally distinct from MR approaches, called Genetic
Correlation Contrast for Causality (G3C) to test the existence and direction of a causal
relationship between two phenotypes. G3C makes causal inference based on a new theory
on genetic correlation heterogeneity. Therefore it uses GWAS results across all the SNPs
and does not rely on the ‘no horizontal pleiotropy’ assumption. These make G3C a useful
method for triangulation in causal inference using observational data, particularly GWAS
data. G3C can be implemented based solely on GWAS summary statistics, using HDL,
the method we developed in Study II, to estimate genetic correlations accurately.
Chapter 7
Summary of studies
Data sources
Individual-level data:
The Swedish Twin Registry (TwinGene): Approximately 10,000 genotyped individuals
were deep phenotyped. There are 644,556 directly genotyped SNPs, which are imputed to
2,585,290 SNPs using Hapmap 2 build 36.
1000 Genomes: The 1000 Genomes Project applied whole-genome sequencing to a
diverse set of individuals from multiple populations. The 1000 Genomes phases 3 data
reconstructed the genomes of 2,504 individuals from 26 populations, including 503 Eu-
ropean ancestry samples, using a combination of low-coverage whole-genome sequencing,
deep exome sequencing, and dense microarray genotyping. The data are publicly available.
UK Biobank: Participants were recruited from the general UK population across 22
centers between 2006-2010 (102). Subjects were aged 40-69 at baseline, underwent exten-
sive phenotyping by questionnaire and clinic measurements, and provided a blood sample.
In total 502,664 subjects had been genotyped on an Affymetrix chip including 800,000
variants, that had already been imputed to millions of variants. These individuals had
complete phenotyping where various measurements and disease outcomes are included.
Summary-level data:
UK Biobank GWAS round 2 by Neale’s group: GWAS on ∼336,000 unrelated individ-
uals of British ancestry for over 2,000 of the available phenotypes in UK Biobank. Age,
age2, inferred sex, age × inferred sex, age2 × inferred sex, and PCs 1-20 were adjusted.
GIANT consortium: The Genetic Investigation of ANthropometric Traits (GIANT)
consortium performed GWAS meta-analysis on several anthropometric traits. We used
results for six anthropometric traits: BMI, height, weight, hip circumference (HIP), waist
circumference (WC) and waist-to-hip ratio (WHR). BMI data are from Locke et al. (103);
height data are from Wood et al. (104); weight data are from Randall et al. (105); HIP,
WC and WHR data are from Shungin et al. (9).
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Study I
Title:
A selection operator for summary association statistics reveals allelic heterogeneity of com-
plex traits
Background:
Many loci mapped in GWAS harbour multiple causal variants. Conditional and joint
multi-variant analysis (GCTA-COJO) has been widely used in discovering additional as-
sociation signals within detected loci. There is theoretical and empirical evidence that the
least absolute shrinkage and selection operator (LASSO) provides a better variable selec-
tion procedure than stepwise selection procedures, which is implemented in GCTA-COJO.
Aims:
We aimed to obtain LASSO result using GWAS summary statistics (SOJO), and imple-
ment SOJO on genomic loci discovered in standard GWAS, for fine-mapping purpose.
Results:
We mathematically proved that LASSO can be achieved using summary-level data and
is approximately equivalent to LASSO based on individual-level data. We showed that
SOJO provides better sensitivity and specificity in evaluating the number of variants
with independent effects in each locus. SOJO suggests causal variants which may be
missed by GCTA-COJO. According to our empirical results, human height is not only
a highly polygenic trait but also has high allelic heterogeneity within its established
hundreds of loci. We built an R package sojo, which is available in R-Forge (https://
r-forge.r-project.org/R/?group_id=2030). A help document can be found at https:
//github.com/zhenin/sojo.
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Figure 7.1: An example showing the approximation of SOJO to individual-level LASSO. The
GWAS are based on 120,086 individuals in the UKB. The curves represent regularization paths
of LASSO coefficients. (A) LASSO based on individual-level data. (B) SOJO based on GWAS
summary statistics and LD correlations estimated from the GWAS sample. (C) SOJO based on
GWAS summary statistics and LD correlations estimated from 9,617 TwinGene individuals.
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Study II
Title:
High-definition likelihood inference of genetic correlations across human complex traits
Background:
Genetic correlation is a key parameter in genetics and genetic epidemiology. Historically,
genetic correlation was estimated by using family design data. Currently, when SNP
data became available, GREML was used to estimate genetic correlation from LMM,
where individual-level genotype data were needed. To estimate genetic correlation from
summary-level data, LDSC was developed based on the same LMM as in GREML. How-
ever, standard errors of genetic correlation estimates by LDSC were observed to be sub-
stantially larger than those of GREML.
Aims:
We aimed to estimate genetic correlations with a full likelihood-based method using
summary-level data.
Results:
We noticed that LDSC only partially uses LD information in the modelling of summary
association statistics. We developed HDL, a likelihood-based method which is a natural
extension of LDSC but fully accounting for LD information. We compared HDL and
LDSC in both simulation and application on UKB. Comparing to LDSC, HDL reduces
the variance of a genetic correlation estimate by about 60%, which is equivalent to a 2.5-
fold increase in sample size. Therefore HDL has higher statistical power to detect genetic
correlations between phenotypes. We developed an R package HDL, which is hosted on
GitHub (https://github.com/zhenin/HDL).
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Figure 7.2: The power gain of HDL
on genetic correlation estimates over
LDSC. The complete version of this
plot with trait names can be found
in Fig. 2 of Study II. Genetic cor-
relation estimates that were signifi-
cantly different from zero in only one
method are marked with asterisk and
black square. Lower triangle: HDL
estimates; upper triangle: LDSC esti-
mates.
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Study III
Title:
Nontrivial replication of loci detected by multi-trait methods
Background:
Various multi-trait methods have been used to obtain higher discovery power than univari-
ate GWAS. However, the replication strategy for SNPs discovered by multi-trait methods
has yet to be agreed upon.
Aims:
We aimed to develop more rigorous replication strategies for loci detected by multi-trait
methods.
Results:
We introduced Monte-Carlo based correlation methods for evaluating the consistency of
multi-trait genetic associations between the discovery and replication samples. By simu-
lations under different scenarios, we illustrated the replication strength of four methods:
(i) MANOVA, as a representative of multivariate methods providing unsigned omnibus p-
values; (ii) phenotype score replication; (iii) Pearson correlation method; and (iv) Kendall
correlation method. Implementation of these methods only requires summary association
statistics. Then we proposed a four-level replication strategy for replication of loci detected
by multi-trait methods. To demonstrate the application of the four-level replication strat-
egy, we studied the SNPs discovered by MANOVA using GWAS summary statistics from
the GIANT consortium as an example and replicated them in UKB.
Figure 7.3: Flowchart illustrating the four methods and the questions they can answer.
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Study IV
Title:
Inferring causation from heterogeneity in genetic correlations of complex traits
Background:
Causal inference plays an essential role in epidemiology and biomedical science. The gold
standard method RCT is powerful but is often infeasible due to cost or ethical and practi-
cal concerns. The emerging genetic data popularise MR, where genetic variants are used
as IVs. Although MR is easy to use, it relies on the ‘no horizontal pleiotropy’ assumption.
This assumption is often violated in real analysis, especially when the IVs are selected
through blind screening from GWAS, and there is a genetic correlation between exposure
and outcome.
Aims:
We aimed to develop and implement a test, which is free from the no horizontal pleiotropy
assumption, for the existence and direction of a causal relationship between two pheno-
types.
Results:
We developed G3C to test for causal inference using GWAS summary statistics. G3C does
not rely on the no horizontal pleiotropy assumption, which makes it take full advantage
of GWAS results and account for underlying genetic correlation between complex traits.
We applied G3C on UKB and discovered new causalities. We performed two-sample MR
analysis on G3C discoveries and found significant consistency between the two methods.
Figure 7.4: Directed acyclic graph shows the parameterization for G3C. gexp and gout are mod-
elled as random effects. The inference is based on the heterogeneity in genetic correlation
rG = cor(Gexp, Gout) between different samples.
Chapter 8
Future directions
Because of the advances in biotechnologies, biological data collection has been becoming
faster, cheaper and more accessible. Not only for genotypes and phenotypes but also
for gene expression and different omics information in various tissues and cell types, the
amount of multi-level biological data are increasing rapidly. Therefore, in the future of
GWAS, we can foresee that GWAS will be done (i) for more phenotypes, (ii) with more
individuals, (iii) for different levels of omics data in different tissues, and (iv) in different
ethnic groups.
The growing number of individuals in GWAS highlights the advantage of summary-
level methods: they are computationally fast and can use available data without pooling
individual information. The major challenge, also the opportunity of summary-level meth-
ods would be the integration of GWAS results from different levels of biological data.
As an example, stratified LDSC (106) incorporates functional annotation into LDSC and
enables heritability enrichment analysis. A similar feature can be naturally added to HDL.
Some interesting attempts have been made by using heritability enrichment analysis.
For example, Bryois et al. identified cell types underlying brain complex traits by inte-
grating GWAS results with single-cell transcriptomic data (107). However, it is usually
difficult to evaluate the correctness of results from such complex analysis. Therefore meth-
ods based on distinct assumptions, models, biological levels of data and ethnics could be
essential for triangulation purposes. As an example of triangulation, colocalization has
been successfully applied in many fine-mapping studies (25).
LD information is crucial for summary-level methods. In most summary-level methods,
a reference sample with individual-level genotype data is needed for estimating LD. The
estimated LD will then be used to approximate the LD in the GWAS sample. Because
a reference sample with larger sample size generates more accurate LD estimates, large
publicly available cohorts such as UK Biobank are still in great need. If accurate LD
information becomes available for a wider range of ancestries, summary-level methods can
be more widely used.
In summary, we are in an era where it is easier to generate data than to interpret them.
More methodology and analysis efforts are needed so that we can turn piles of data into
useful biological knowledge.
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